Company Name: Bionomics
Announcement Date: 08/11/2016
Announcement Category: Awards/recognition, Other, Product launch/update
Announcement Content:
Australian drug discovery company Bionomics (ASX: BNO) has gained national media coverage following positive results from a clinical trial of BNC-210 as a potential treatment for generalised anxiety disorder. Watch the news story by clicking the link below.
Announcement URL: https://au.news.yahoo.com/video/watch/33130856/trials-look-positive-for-new-anxiety-drug/#page1
About Bionomics:
Bionomics is an Adelaide-based biopharmaceutical company dedicated to making better treatments for cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. We are in a strong growth phase with our world-class portfolio of promising drug candidates from early to advanced stages of clinical development. At the core of our business is strategic partnering. We partner with large pharmaceutical companies to get our drugs through the later stages of development and into the market as rapidly as possible.
Go to Company Profile for: Bionomics
Announcement Contact: [email protected]
